Dading, Latip .
HRN: 23-56-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2024
CLINDAMYCIN 300MG (CAP)
01/07/2024
01/13/2024
ORAL
300mg
Tid
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes